Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: MAZE

Maze Therapeutics, Inc.

Healthcare | Biotechnology

No licensed closing price on file for MAZE. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Maze Therapeutics, Inc. (NASDAQ: MAZE) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 03:16 UTC.

Key facts

Valuation
Return on equity-16.78%
Debt/equity0.09

Charts

Charts are in the appInteractive charts for MAZE are available in Oxford Ledge.
Open MAZE in Oxford Ledge →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-02
  • 2026-10-02Chief Executive OfficerSale-2,593$70.1K
  • 2026-10-02Chief Executive OfficerSale-31,908$862.2K
  • 2026-10-02President, R&D & CMOSale-16,141$434.7K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Maze Therapeutics, Inc. do?

Maze Therapeutics, Inc. is a biotechnology company, listed on NASDAQ as MAZE.

When did MAZE last file with the SEC?

Maze Therapeutics, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-10. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 03:16 UTC. This page is also available as JSON at /api/data?ticker=MAZE and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for MAZE and 5,000+ tickers.

Create a free account — keep MAZE
For your agent
GET /api/data?ticker=MAZE

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt